48% of Americans don’t know risks of daily, low-dose aspirin outweigh benefits, survey says
Nearly half of survey respondents (48%) incorrectly said that the benefits of taking low-dose aspirin daily to lower one’s odds ...
Tag: Genetics
Merck-AstraZeneca breast cancer drug Lynparza improves long-term survival, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in ...
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!